Most Recent
Austin Engineering needs more evidence for freezing order against ex-sales rep: court
A judge has denied Austin Engineering’s bid for a $210,000 freezing order against a former sales representative, with a judge finding there was an arguable claim for breach of confidence but no evidence of a claim to more than nominal damages. 
Apple defeats patent infringement suit over Touch ID technology
Apple has defeated a claim by an Australian non-practicing entity that its patents for a remote entry system were infringed by the tech company’s Touch ID and Face ID technology. 
Sandoz says Amgen ‘dragging the chain’ in fight over bone drug biosimilar
Sandoz has accused Amgen of 'dragging the chain' as the Swiss biotech continues to mull whether to launch infringement proceedings over six patents for its Prolia and Xgeve bone disease biologics.
Canva inventions might be useful, but no method of manufacture, IP Australia says
IP Australia has rejected two patents by online graphic design company Canva, with a delegate dismissing the company's argument the computer-implemented patent applications claim a manner of manufacture.
Sandoz moves to block Amgen’s attorneys from prosecuting patents in IP spat
Generic drug maker Sandoz wants to shield information turned up by preliminary discovery orders from the eyes of Amgen patent attorneys in a spat over cheap versions of Amgen's bone disease drugs, and says if they view the material they should be barred from prosecuting future related patents.
Momofuku restaurant loses challenge to instant Ramen maker’s trade mark
Famed restaurant chain Momofuku has lost its challenge to the ‘Momofuku’ word mark of instant noodle giant Nissin, with IP Australia finding consumers were not likely to be deceived or confused because of the different goods and services provided by the two companies.
Fonterra to appeal ruling over Bega trade mark licences
Dairy company Fonterra is reportedly challenging a court's refusal to give it certainty over lucrative licence agreements with Bega Cheese as it pursues a sale of its Australian business.
Amgen wants Sandoz to give up info on regulatory approval for generic Prolia, Xgeva
Biopharmaceutical company Amgen has lodged proceedings against generic maker Sandoz, calling for documents related to regulatory approval of a generic version of its top-selling bone disease treatments.
Vehicle Management Systems wins extension to renew patents after forgetting to pay fees
A company that manufactures vehicle sensing technology used to monitor public parking has been allowed more time to renew its patents, despite opposition from rival SARB.
Foxtel wins security in $12M dispute over download patent
The owner of a patent for software allowing users to download live television that is suing Foxtel for $12 million has been ordered to cough up $260,000 in security.